Início > All categories> Biochemicals and Pharmaceutical Chemicals> Pharmaceutical Impurities> Raltegravir potassium

Raltegravir potassium

Obter o preço mais recente >

Preço fob contact us for price

Origem: China

Cas No: 871038-72-1

Especificação: 99%Min

Quantidade de ordem min: 1 /kg

Capacidade de fornecimento: 100 mt/month

Tempo de espera: 7 dias para OEM, 3 dias para produtos prontos

Fornecedor:

Condições de pagamento:

Inquérito agora

* Envie um inquérito para nós

Adicionar a lista de desejos

* Diga seu preço
* Iniciar o pedido não significa comprar agora

Especificação de produtos
Descrição do produto

Property

CAS No.: 871038-72-1 Formula: C20H20FKN6O5 Molecular Weight: 482.50700

Description

Raltegravir (RAL, Isentress, formerly MK-0518) is an antiretroviral drug produced by Merck & Co., used to treat HIV infection. It received approval by the U.S. Food and Drug Administration (FDA) on 12 October 2007, the first of a new class of HIV drugs, the integrase inhibitors, to receive such approval.
In December 2011, it received FDA approval for pediatric use in patients ages 2–18, taken in pill form orally twice a day by prescription with two other antiretroviral medications to form the cocktail (most anti-HIV drugs regimens for adults and children use these cocktails). Raltegravir is available in chewable form, but because the two tablet formulations are not interchangeable, the chewable pills are only approved for use in children two to 11. Older adolescents will use the adult formulation.

Basic Info

Chemical Name	Raltegravir potassium
Synonyms	N-[(4-Fluorophenyl)methyl]-1,6-dihydro-5-hydroxy-1-methyl-2-[1-methyl-1-[[(5-methyl-1,3,4-oxadiazol-2-yl)carbonyl]amino]ethyl]-6-oxo-4-pyrimidinecarboxamide Potassium Salt; Raltegravir (potassium salt); MK 0518; Raltegravir K; Raltegravir(MK-0518); Raltegravirpotassium;
CAS No.	871038-72-1
Molecular Formula	C20H20FKN6O5
Molecular Weight	482.50700
PSA	155.07000
LogP	2.13150